Johnson & Johnson to acquire Shockwave Medical for $335/share cash, ~$13.1B EV

Shockwave Medical, Inc.

J&J acquires Shockwave for $335.00/share cash; enterprise value ~$13.1B.
Merger expected to close mid-2024 pending regulatory approvals and stockholder vote.
Shockwave Board recommends adoption; termination fee of $448M payable in certain circumstances.
IVL platform complements J&J MedTech's heart recovery and electrophysiology businesses.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Shockwave Medical, Inc. entered into Agreement and Plan of Merger with Johnson & Johnson, Sweep Merger Sub, Inc. valued at $335.00 per share (effective 2024-04-04).

Action: entry
Agreement: merger
Counterparty: Johnson & Johnson, Sweep Merger Sub, Inc.
Value: $335.00 per share
Effective: 2024-04-04

Exact text from the filing

On April 4, 2024, Shockwave Medical, Inc., a Delaware corporation (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Johnson & Johnson, a New Jersey corporation (“Parent”), and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), providing for the merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent.

View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001193125-24-087890

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.